To award a Congressional Gold Medal to Malala Yousafzai, a recipient of the Nobel Prize for Peace, in recognition of her devoted service to education, justice, and equality in Pakistan.
Legislative Progress
Introduced
January 6, 2015
Latest Action
January 6, 2015
Primary Sponsor
Sheila Jackson LeeDemocratic(TX)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 6,526 other HR bills in the 114th — cohort avg 56d
Directs the Speaker of the House of Representatives and the President pro tempore of the Senate to arrange for the presentation of a congressional gold medal to Malala Yousufzai in recognition of her devoted service to education, justice, and equality in Pakistan.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2015 · second_quarter · Medicare/Medicaid
Legislative and regulatory issues that affect the prescription drug benefit or prescription drug affordability, including: HR244 (MAC Pricing); HR471 (Controlled Substances Registration); HR592 (Pharmacy Provider Status); HR69 (ASP Prompt Pay Exclusion); HR793 (Any Willing Pharmacy); HR804 (Access to Medicare Data); HR818 (PRIME Act); HR971 (OPEN Act); HR1021 (PIMA); HR1353 (New Therapeutic Entities); HR1735 (NDAA); HR2175 (FEHBP Transparency); HR2298 (Medicare Rx Abuse Prevention); S31 (Direct Negotiation); S314 (Pharmacy Provider Status); S1083 (Medicare Rebates); S1190 (Any Willing Pharmacy); S1364 (Medicaid Generic Rebates); S1376 (NDAA); S1431(Rx Abuse Prevention & Treatment).
Referred to the House Committee on Financial Services.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: Not reported · Firm income: Not reported
2015 · second_quarter · Health Issues
Legislative and regulatory issues that affect the prescription drug benefit or prescription drug affordability, including: HR244 (MAC Pricing); HR471 (Controlled Substances Registration); HR592 (Pharmacy Provider Status); HR69 (ASP Prompt Pay Exclusion); HR793 (Any Willing Pharmacy); HR804 (Access to Medicare Data); HR818 (PRIME Act); HR971 (OPEN Act); HR1021 (PIMA); HR1353 (New Therapeutic Entities); HR1735 (NDAA); HR2175 (FEHBP Transparency); HR2298 (Medicare Rx Abuse Prevention); S31 (Direct Negotiation); S314 (Pharmacy Provider Status); S1083 (Medicare Rebates); S1190 (Any Willing Pharmacy); S1364 (Medicaid Generic Rebates); S1376 (NDAA); S1431(Rx Abuse Prevention & Treatment).
Client expense: Not reported · Firm income: Not reported
2015 · second_quarter · Defense
Legislative and regulatory issues that affect the prescription drug benefit or prescription drug affordability, including: HR244 (MAC Pricing); HR471 (Controlled Substances Registration); HR592 (Pharmacy Provider Status); HR69 (ASP Prompt Pay Exclusion); HR793 (Any Willing Pharmacy); HR804 (Access to Medicare Data); HR818 (PRIME Act); HR971 (OPEN Act); HR1021 (PIMA); HR1353 (New Therapeutic Entities); HR1735 (NDAA); HR2175 (FEHBP Transparency); HR2298 (Medicare Rx Abuse Prevention); S31 (Direct Negotiation); S314 (Pharmacy Provider Status); S1083 (Medicare Rebates); S1190 (Any Willing Pharmacy); S1364 (Medicaid Generic Rebates); S1376 (NDAA); S1431(Rx Abuse Prevention & Treatment).
Client expense: Not reported · Firm income: Not reported
2015 · second_quarter · Labor Issues/Antitrust/Workplace
Legislative and regulatory issues that affect the prescription drug benefit or prescription drug affordability, including: HR244 (MAC Pricing); HR471 (Controlled Substances Registration); HR592 (Pharmacy Provider Status); HR69 (ASP Prompt Pay Exclusion); HR793 (Any Willing Pharmacy); HR804 (Access to Medicare Data); HR818 (PRIME Act); HR971 (OPEN Act); HR1021 (PIMA); HR1353 (New Therapeutic Entities); HR1735 (NDAA); HR2175 (FEHBP Transparency); HR2298 (Medicare Rx Abuse Prevention); S31 (Direct Negotiation); S314 (Pharmacy Provider Status); S1083 (Medicare Rebates); S1190 (Any Willing Pharmacy); S1364 (Medicaid Generic Rebates); S1376 (NDAA); S1431(Rx Abuse Prevention & Treatment).
Client expense: Not reported · Firm income: Not reported
2015 · second_quarter · Pharmacy
Legislative and regulatory issues that affect the prescription drug benefit or prescription drug affordability, including: HR244 (MAC Pricing); HR471 (Controlled Substances Registration); HR592 (Pharmacy Provider Status); HR69 (ASP Prompt Pay Exclusion); HR793 (Any Willing Pharmacy); HR804 (Access to Medicare Data); HR818 (PRIME Act); HR971 (OPEN Act); HR1021 (PIMA); HR1353 (New Therapeutic Entities); HR1735 (NDAA); HR2175 (FEHBP Transparency); HR2298 (Medicare Rx Abuse Prevention); S31 (Direct Negotiation); S314 (Pharmacy Provider Status); S1083 (Medicare Rebates); S1190 (Any Willing Pharmacy); S1364 (Medicaid Generic Rebates); S1376 (NDAA); S1431(Rx Abuse Prevention & Treatment).
Client expense: Not reported · Firm income: Not reported
2015 · second_quarter · Postal
Legislative and regulatory issues that affect the prescription drug benefit or prescription drug affordability, including: HR244 (MAC Pricing); HR471 (Controlled Substances Registration); HR592 (Pharmacy Provider Status); HR69 (ASP Prompt Pay Exclusion); HR793 (Any Willing Pharmacy); HR804 (Access to Medicare Data); HR818 (PRIME Act); HR971 (OPEN Act); HR1021 (PIMA); HR1353 (New Therapeutic Entities); HR1735 (NDAA); HR2175 (FEHBP Transparency); HR2298 (Medicare Rx Abuse Prevention); S31 (Direct Negotiation); S314 (Pharmacy Provider Status); S1083 (Medicare Rebates); S1190 (Any Willing Pharmacy); S1364 (Medicaid Generic Rebates); S1376 (NDAA); S1431(Rx Abuse Prevention & Treatment).
Client expense: Not reported · Firm income: Not reported
2015 · second_quarter · Taxation/Internal Revenue Code
Legislative and regulatory issues that affect the prescription drug benefit or prescription drug affordability, including: HR244 (MAC Pricing); HR471 (Controlled Substances Registration); HR592 (Pharmacy Provider Status); HR69 (ASP Prompt Pay Exclusion); HR793 (Any Willing Pharmacy); HR804 (Access to Medicare Data); HR818 (PRIME Act); HR971 (OPEN Act); HR1021 (PIMA); HR1353 (New Therapeutic Entities); HR1735 (NDAA); HR2175 (FEHBP Transparency); HR2298 (Medicare Rx Abuse Prevention); S31 (Direct Negotiation); S314 (Pharmacy Provider Status); S1083 (Medicare Rebates); S1190 (Any Willing Pharmacy); S1364 (Medicaid Generic Rebates); S1376 (NDAA); S1431(Rx Abuse Prevention & Treatment).
Client expense: Not reported · Firm income: Not reported
2015 · first_quarter · Marine/Maritime/Boating/Fisheries
Advocate for H.R. 1335 and H.R. 774 (formerly H.R. 69) Data inquiries for NOAA on tilefish quota/harvest
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Natl Oceanic & Atmospheric Administration (NOAA), SENATE
2015 · first_quarter · Marine/Maritime/Boating/Fisheries
Advocate for H.R. 1335 and H.R. 774 (formerly H.R. 69) Oppose State management of red snapper in the Gulf of Mexico (i.e. S.105; H.R. 981)
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · first_quarter · Marine/Maritime/Boating/Fisheries
Advocate for H.R. 1335 and H.R. 774 (formerly H.R.69) Schedule meeting with NOAA to discuss adequate West Coast fisheries surveys Support Dungeness Crab State jurisdiction authority & REFI legislation Support Endangered Salmon & Fisheries Predation Prevention Act Discuss West Coast fisheries issues with new House Subcommittee staff Advocate for a permanent NPDES permit moratorium for the commercial fishing industry in S.373/S.371
Client expense: Not reported · Firm income: $9,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Oceanic & Atmospheric Administration (NOAA), SENATE
2015 · first_quarter · Marine/Maritime/Boating/Fisheries
NOAA/MAFMC public hearing & comments on deep water coral conservation Comments to NOAA on IUU Task Force & Seafood Fraud Advocate for H.R. 1335 and H.R. 774 (formerly H.R. 69) USFWS Import/Export Inspection program fro domestic squid products
Client expense: Not reported · Firm income: $7,950
Government targets: HOUSE OF REPRESENTATIVES, Natl Oceanic & Atmospheric Administration (NOAA), SENATE, State, Dept of (DOS)
2015 · first_quarter · Marine/Maritime/Boating/Fisheries
NOAA/MAFMC public hearing & comments on deep water coral conservation Comments to NOAA on IUU Task Force & Seafood Fraud Advocate or H.R. 1335 and H.R. 774 (formerly H.R. 69) Support NJ Sen. Booker as Commerce Subcommittee Ranking Member Support NJ House & Senate staff positions on offshore drilling Attend National Ocean Policy Coalition House meetings for client
Client expense: Not reported · Firm income: $7,500
Government targets: HOUSE OF REPRESENTATIVES, Natl Oceanic & Atmospheric Administration (NOAA), SENATE
| Democratic |
| FL |
| André Carson | Democratic | IN |
| Ann Kirkpatrick | Democratic | AZ |
| Ann M. Kuster | Democratic | NH |
| Barbara Lee | Democratic | CA |
| Betty McCollum | Democratic | MN |
| Blake Farenthold | Republican | TX |
| Bobby L. Rush | Democratic | IL |
| Charles B. Rangel | Democratic | NY |
| Cheri Bustos | Democratic | IL |
| Corrine Brown | Democratic | FL |
| Daniel M. Donovan, Jr. | Republican | NY |
| Daniel T. Kildee | Democratic | MI |
| David N. Cicilline | Democratic | RI |
| Debbie Dingell | Democratic | MI |
| Dina Titus | Democratic | NV |
| Eddie Bernice Johnson | Democratic | TX |
| Edward R. Royce | Republican | CA |
| Eleanor Holmes Norton | Democratic | DC |
| Elijah E. Cummings | Democratic | MD |
| Elizabeth H. Esty | Democratic | CT |
| Frederica S. Wilson | Democratic | FL |
| Gwen Moore | Democratic | WI |
| Hakeem S. Jeffries | Democratic | NY |
| Jackie Speier | Democratic | CA |
| James P. McGovern | Democratic | MA |
| Janice D. Schakowsky | Democratic | IL |
| Janice Hahn | Democratic | CA |
| Jim McDermott | Democratic | WA |
| Juan Vargas | Democratic | CA |
| Judy Chu | Democratic | CA |
| Julia Brownley | Democratic | CA |
| Katherine M. Clark | Democratic | MA |
| Kay Granger | Republican | TX |
| Lois Frankel | Democratic | FL |
| Louise McIntosh Slaughter | Democratic | NY |
| Madeleine Z. Bordallo | Democratic | GU |
| Marc A. Veasey | Democratic | TX |
| Marcia L. Fudge | Democratic | OH |
| Marcy Kaptur | Democratic | OH |
| Matt Cartwright | Democratic | PA |
| Michael M. Honda | Democratic | CA |
| Nita M. Lowey | Democratic | NY |
| Raúl M. Grijalva | Democratic | AZ |
| Scott H. Peters | Democratic | CA |
| Sean Patrick Maloney | Democratic | NY |
| Steve Cohen | Democratic | TN |
| William R. Keating | Democratic | MA |
| Yvette D. Clarke | Democratic | NY |